Thakar Sumedh S sold $567K of QLYS

Thakar Sumedh S (CEO & PRESIDENT) sold 3,200 shares of QUALYS, INC. (QLYS) at an average of $177.27 ($170.39–$181.81, $0.57M total) across 9 trades on 2026-11-16 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Thakar Sumedh S
Published Nov 17, 2026, 9:26 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 17, 2026, 10:00 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$QLYS
Neutral
high confidence
Mentioned
$QLYS
Relevance
4/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$QLYSNeutralLow
01

Why it matters

Traders may monitor for patterns in insider activity, but this specific filing does not introduce new company-specific fundamentals or a time-sensitive corporate event.

02

Market read

Useful as a sentiment/positioning datapoint for QLYS, but unlikely to drive a durable repricing absent additional catalysts.

03

What to watch

The disclosure does not indicate whether sales were part of a larger scheduled cadence, nor does it provide context for tax planning or diversification; without that, signal quality is low.

Relevance 4/10Novelty 3/10Timing: filed after-hours on 2026-11-17, for next-session positioning

Background

The article summarizes an SEC Form 4 insider transaction by Qualys CEO and President Thakar Sumedh S, including trade dates, prices, and post-sale holdings.

Company-level read

Ticker impact

$QLYSNeutralHigh confidence
Context

Qualys CEO and President Thakar Sumedh S sold about 3,200 shares for roughly $567K under a pre-arranged 10b5-1 plan, per Form 4 filed today.

Expected impact

Likely limited near-term impact as the sale is explicitly under a pre-arranged 10b5-1 plan, with any reaction fading quickly.

Evidence & confidence

The filing is an SEC Form 4 insider transaction with no accompanying guidance, deal, or regulatory action; 10b5-1 typically reduces interpretive signal.

Market effects

Minimal. Insider selling at a single cybersecurity name does not materially change sector fundamentals.

None.

None.

Counterpoint

Even with 10b5-1, repeated insider selling can coincide with personal liquidity needs or reduced conviction, which some traders may still front-run.

Key entities

  • QUALYS, INC.

    US-listed cybersecurity company whose CEO filed an SEC Form 4 insider sale.

  • Thakar Sumedh S

    CEO and President who sold shares under a pre-arranged Rule 10b5-1 plan.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$QLYSMed

Qualys Shares Climb 9% On Expanded Cognizant Alliance

Qualys (QLYS) shares rose 9% after announcing an expanded alliance with Cognizant (CTSH). The stock traded at $189.91, up from $177.68. The partnership combines Cognizant's Cyber Vulnerability Management with Qualys' TruRisk Management for AI-powered cyber risk services.

$QLYSHighAI 8/10

Qualys Earnings Call Highlights Growth and Automation

Qualys (QLYS) reported Q3 revenue of $188M, up 11% YoY, with adjusted EBITDA at $89.9M (48% margin). The company raised 2026 revenue guidance to $736.9M-$738.9M (10% growth). Key growth drivers include autonomous remediation, large customer momentum, and federal wins. However, concerns include flat expansion, higher expenses, and softer Q4 billings outlook.

$QLYSHigh

Why is Qualys stock tumbling today?

Qualys (QLYS) stock fell 10.5% after reporting Q3 earnings that beat estimates but provided weaker-than-expected Q4 billings growth guidance. The company reported adjusted EPS of $2.12 and revenue of $188M, up 11% YoY. Analysts responded with cautious notes, adjusting price targets downward. The broader market and cybersecurity sector also declined, but Qualys underperformed due to its guidance miss.